Hereditary hemochromatosis - A new look at an old disease

New England Journal of Medicine

Volumn 350, Issue 23, 2004, Pages 2383-2397+2430

  Pietrangelo, Antonello ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN 1; GENE PRODUCT; HEMOJUVELIN; HEPCIDIN; HFE PROTEIN; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN; TFR2 PROTEIN, HUMAN;

ANEMIA; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENE; GENETIC DISORDER; GENETIC VARIABILITY; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HFE GENE; HUMAN; IRON OVERLOAD; JUVENILE HEREDITARY HEMOCHROMATOSIS; MASS SCREENING; PATHOGENESIS; PHENOTYPE; PHENOTYPIC VARIATION; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW; TFR2 GENE; GENETICS; GENOTYPE; HOMEOSTASIS; METABOLISM; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIMICROBIAL CATIONIC PEPTIDES; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMEOSTASIS; HUMANS; IRON; IRON OVERLOAD; MEMBRANE PROTEINS; MUTATION; PHENOTYPE; RECEPTORS, TRANSFERRIN;

EID: 2542560427     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra031573     Document Type: Review

References (102)

1. Glycosurie: diabete sucre. In: Trousseau A. clinique medicale de l'Hotel-Dieu de Paris. Vol. 2. Paris: J.-B. Bailliere, 1865:663-98.
2. Troisier M. Diabète sucré. Bull Soc Anat Paris 1871;44:231-5.
3. von Recklinghausen FD. Uber Haemochromatose. Tageblatt Versammlung Dtsche Naturforscher Arzte Heidelberg 1889;62:324-5.
4. Sheldon JH. Haemochromatosis. London: Oxford University Press, 1935.
5. Simon M, Pawlotsky Y, Bourel M, Fauchet R, Genetet B. Hémochromatose idiopathique maladie associée à l'antigene tissulaire HL-A 3. Nouv Presse Med 1975;4:1432.
6. Simon M, LeMignon L, Fauchet R, et al. A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am J Hum Genet 1987;41:89-105.
7. Feder JN, Gnírke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
8. Hemochromatosis. In: Online Mendelian Inheritance in Man, OMIM. Baltimore: MeKusick-Nathans Institute for Genetic Medicine, 2000. (Accessed May 10, 2004, at http://www.ncbi.nlm.nih.gov/omim/.)
9. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
10. Roehette J, Pointon JJ, Fisher CA, et al. Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet 1999;64:1056-62. [Erratum, Am J Hum Genet 1999;64:1491.]
11. Roehette J, Pointon JJ, Fisher CA, et al. Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet 1999;64:1056-62. [Erratum, Am J Hum Genet 1999;64:1491.]
12. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002;122:646-51. [Erratum, Gastroenterology 2002;122:1191.]
13. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002;122:646-51. [Erratum, Gastroenterology 2002;122:1191.]
14. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999;93:2502-5.
15. Pointon JJ, Wallace D, Merryweather-Clarke AT, Robson KJ. Uncommon mutations and polymorphisms in the hemochromatosis gene. Genet Test 2000;4:151-61.
16. Wallace DF, Walker AP, Pietrangelo A, et al. Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y. J Hepatol 2002;36:474-9.
17. Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-5.
18. Mattman A, Huntsman D, Lockitch G, et al. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C2828Y iron overload: identification of a novel TfR-2 mutation. Blood 2002;100:1075-7.
19. Girelli D, Bozzini C, Roetto A, et al. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology 2002;122;1295-302.
20. Hattori A, Wakusawa S, Hayashi H, et al. AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. Hepatol Res 2003;26:154-6.
21. Pietrangelo A. Hemochromatosis 1998: is one gene enough? J Hepatol 1998;29:502-9.
22. Cazzola M, Cerani P, Rovati A, Iannone A, Claudiani G, Bergamaschi G. Juvenile genetic hemochromatosis is clinically and genetically distinct from the classical HLA-related disorder. Blood 1998;92:2979-81.
23. De Gobbi M, Roetto A, Piperno A, et al. Natural history of juvenile haemochromatosis. Br J Haematol 2002;117:973-9.
24. Lamon JM, Marynick SP, Roseblatt R, Donnelly S. Idiopathic hemochromatosis in a young female: a case study and review of the syndrome in young people. Gastroenterology 1979;76:178-83.
25. Cazzola M, Ascari E, Barosi G, et al. Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet 1983;65:149-54.
26. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21-2.
27. Roetto A, Totaro A, Cazzola M, et al. Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet 1999;64:1388-93.
28. Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82.
29. Lebron JA, Bennett MJ, Vaughn DE, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998;93:111-23.
30. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 1998;95:1472-7.
31. Waheed A, Parkkila S, Zhou XY, et al. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A 1997;94:12384-9.
32. Gross CN, Irrinki A, Feder JN, Enns CA. Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem 1998;273:22068-74.
33. Lebron JA, West AP Jr, Bjorkman PJ. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. J Mol Biol 1999;294:239-45.
34. Salter-Cid L, Brunmark A, Li Y, et al. Transferrin receptor is negatively modulated by the hemochromatosis protein HFET implications for cellular iron homeostasis. Proc Natl Acad Sci U S A 1999;96:5434-9.
35. Montosi G, Paglia P, Garuti C, et al. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 2000;96:1125-9.
36. Drakesmith H, Sweetland E, Schimanski L, et al. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc Natl Acad Sci U S A 2002;99:15602-7.
37. Waheed A, Grubb JH, Zhou XY, et al. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci. U S A 2002;99:3117-22.
38. Zhang AS, Davies PS, Carlson HL, Enns CA. Mechanisms of HFE-induced regulation of iron homeostasis: insights from the W81A HFE mutation. Proc Natl Acad Sci U S A 2003;100:9500-5.
39. Davies PS, Zhang AS, Anderson EL, et al. Evidence for the interaction of the hereditary haemochromatosis protein, HFE, with the transferrin receptor in endocytic compartments. Biochem J 2003;373:145-53.
40. Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2: a new member of the transferrin receptor-like family. J Biol Chem 1999;274:20826-32.
41. West. AP Jr, Bennett MJ, Sellers VM, Andrews NC, Enns CA, Bjorkman PJ. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem 2000;275:38135-8.
42. Kawabata H, Germain RS, Vuong PT, Nakamaki T, Said JW, Koeffler HP. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem 2000;275:16618-25.
43. Fleming RE, Migas MC, Holden CC, et al. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A 2000;97:2214-9.
44. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-50.
45. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-10.
46. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-9.
47. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-8.
48. Cook JD, Barry WE, Hershko C, Fillet G, Finch CA. Iron kinetics with emphasis on iron overload. Am J Pathol 1973;72:337-43.
49. Cavill I, Ricketts C, Jacobs A. Erythropoiesis, iron stores and tissue iron exchange in man. Clin Sci (Lond) 1979;56:223-6.
50. Lynch SR, Skikne BS, Cook JD. Food iron absorption in idiopathic hemochromatosis. Blood 1989;74:2187-93.
51. Smith PM, Godfrey BE, Williams P, Iron absorption in idiopathic haemochromatosis and its measurement using a whole-body counter. Clin Sci 1969;37:519-31.
52. Astaldi G, Meardi G, Lisino T. The iron content of jejunal mucosa obtained by Crosby's biopsy in hemochromatosis and hemosiderosis. Blood 1966;28:70-82.
53. Pietrangelo A, Rocchi E, Casalgrandi G, et al. Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum. Gastroenterology 1992;102:802-9.
54. Crosby WH. The control of iron balance by the intestinal mucosa. Blood 1963;22:441-9.
55. Parkkila S, Waheed A, Britton RS, et al. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci U S A 1997;94:2534-9.
56. Andrews NC, Fleming MD, Gunshin H. Iron transport across biologic membranes. Nutr Rev 1999;57:114-23.
57. Zoller H, Koch RO, Theurl I, et al. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 2001;120:1412-9.
58. Polfs A, Bonkovsky RL, Kohiroser JG, et al. Intestinal expression of genes involved in iron absorption in humans. Am J Physiol Gastrointest liver Physiol 2002;282:G598-G607.
59. McLaren GD, Nathanson MH, Jacobs A, Trevett D, Thomson W. Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis. J Lab Clin Med 1991;117:390-401.
60. Pietrangelo A, Casalgrandi G, Quaglino D, et al. Duodenal ferritin synthesis in genetic hemochromatosis. Gastroenterology 1995;108:208-17. [Erratum, Gastroenterology 1995;108:1963.]
61. Pietrangelo A, Casalgrandi G, Quaglino D, et al. Duodenal ferritin synthesis in genetic hemochromatosis. Gastroenterology 1995;108:208-17. [Erratum, Gastroenterology 1995;108:1963.]
62. Muckenthaler M, Poy CN, Custodio AO, et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet 2003;34:102-7.
63. Bothwell TH. Overview and mechanisms of iron regulation. Nutr Rev 1995;53:237-45.
64. Cairo G, Pecalcati S, Montosi G, Castrusini E, Conte D, Pietrengelo A. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood 1997;89:2546-53.
65. Fillet G, Beguin Y, Baldelli L. Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood 1989;74:844-51.
66. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003;361:669-73.
67. Gehrke SG, Kulaksiz H, Herrmann T, et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 2003;102:371-6.
68. Nicolas G, Viatte L, Lou DQ, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003;34:97-101.
69. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2461-3.
70. Fleming RE, Ahmann JR, Migas MC, et al. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci U S A 2002;99:10653-8.
71. Griffiths WJ, Cox TM. Co-localization of the mammalian hemochromatosis gene product (HFE) and a newly identified transferrin receptor (TfR2) in intestinal tissue and cells. J Histochem Cytochem 2003;51:613-24.
72. Merryweather-Clarke AT, Cadet E, Bomford A, et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 2003;12:2241-7.
73. Hofmann WK, Tong XJ, Ajioka RS, Kushner JP, Koeffler HP. Mutation analysis of transferrin-receptor 2 in patients with atypical hemochromatosis. Blood 2002;100:1099-100.
74. Guyader D, Jacquelinet C, Moirand R, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-36.
75. Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003;138:627-33. [Erratum, Ann Intem Med 2003;139:235.]
76. Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003;138:627-33. [Erratum, Ann Intern Med 2003;139:235.]
77. Powell LW. Diagnosis of hemochromatosis. Semin Gastrointest Dis 2002;13:80-8.
78. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-62.
79. Tavill AS. Diagnosis and management of hemochromatosis. Hepatology 2001;33:1321-8.
80. Wojcik JP, Speechley MR, Kertesz AE, Chakrabarti S, Adams PC. Natural history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol 2002;16:297-302.
81. EASL International Consensus Conference on Haemochromatosis. III. Jury document. J Hepatol 2000;33:496-504.
82. Finch SC, Finch CA. Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis. Medicine (Baltimore) 1955;34:381-430.
83. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355-62.
84. Willis G, Wimperis JZ, Smith KC, Fellows IW, Jennings BA. Haemochromatosis gene C282Y homozygotes in an elderly male population. Lancet 1999;354:221-2.
85. Brown AS, Gwinn M, Cogswell ME, Khoury MJ, Hemochromatosis-associated morbidity in the United States; an analysis of the National Hospital Discharge Survey, 1979-1997. Genet Med 2001;3:109-11.
86. Beutler E. The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood 2003;101:3347-50.
87. Aijoka RS, Kushner JP. Clinical consequences of iron overload in hemochromatosis homozygotes. Blood 2003;101:3351-3.
88. Asberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-15.
89. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
90. Bulaj ZJ, Ajioka RS, Phillips ID, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000;343:1529-35.
91. Beutler E, Fefitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
92. Pietrangelo A, Montosi G, Totaro A, et al. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med 1999;341:725-32.
93. Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-23.
94. Njajou OT, Vaessen N, Joosse M, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213-4.
95. Gordeuk VR, Caleffi A, Coriadini E, et al. Iron overload in Africans and African-Americans and a common mutation in the SCL4OA1 (ferroportin 1) gene. Blood Cells Mol Dis 2003;31:299-304.
96. Arden KE, Wallace DF, Dixon JL, et al. A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut 2003;52:1215-7.
97. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 1995;9:267-72.
98. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A 1995;92:2539-43.
99. Hayashi A, Wada Y, Suzuki T, Shimizu A. Studies on familial hypotransferrinemia: unique clinical course and molecular pathology. Am J Hum Genet 1993;53:201-13.
100. Kato J, Fujikawa K, Kanda M, et al. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 2001;69:191-7.
101. Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am 2003;32:877-89.
102. Cox TM, Halsall DJ. Hemochromatosis - neonatal and young subjects. Blood Cells Mol Dis 2002;29:411-7.